AI assistant
Sending…
Medtronic plc — Director's Dealing 2021
Sep 1, 2021
29841_dirs_2021-09-01_9a87fa4b-992e-45e7-bbf2-9f4912c10d12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-08-31
Reporting Person: Lerman Bradley E (SVP General Counsel & Corp Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-31 | Ordinary Shares | M | 50775 | $74.84 | Acquired | 99538 | Direct |
| 2021-08-31 | Ordinary Shares | S | 50775 | $134.17 | Disposed | 48763 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-31 | Stock Option (Right to Buy) | $74.84 | M | 50775 | Disposed | 2025-01-27 | Ordinary Shares (50775) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.
F3: This date was previously reported incorrectly as 7/28/2024.
More from Medtronic plc
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Regulatory Filings
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29